Pyrazofurin (
NSC 143095) as the monophosphate derivative is a potent inhibitor of
orotidine 5'-monophosphate (
OMP) decarboxylase of the
pyrimidine pathway and has been proposed to inhibit 5-aminoimidazole-4-carboxamide ribotide (
AICAR) transformylase (EC 2.1.2.3) of the
purine pathway (J. F. Worzalla, and M. J. Sweeney,
Pyrazofurin inhibition of
purine biosynthesis via 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-monophosphate
formyltransferase.
Cancer Res., 40: 1482-1485, 1980). Measurement of levels of
pyrimidine and
purine intermediates in cultured mouse
L1210 leukemia cells has shown that 25 microM
pyrazofurin induces an 8-fold accumulation of OMP and large accumulations of intermediates proximal to the blockade with abrupt decreases in
uridine and
cytidine nucleotides. Considerable increases in the cellular concentrations of N-succino-
AICAR (
SAICAR),
AICAR,
5-formamidoimidazole-4-carboxamide ribotide (
FAICAR),
IMP,
XMP, and GMP at later times indicate that
AICAR transformylase is not significantly inhibited in cultured cells; rather the
purine pathway and the GMP branch are stimulated. However, addition of 25 microM
3-deazauridine (NSC 126849) to
leukemia cells did result in inhibition of
AICAR transformylase:
AICAR and
SAICAR accumulated,
IMP disappeared and there was a large accumulation of
guanosine nucleotides. Blockade of
pyrimidine biosynthesis by derivatives of
pyrazofurin or
3-deazauridine spares 5-phosphoribosyl-1-pyrophosphate and
L-glutamine, elevated concentrations of which may stimulate initial reactions of
purine biosynthesis and the reaction
XMP----GMP.